Literature DB >> 13008201

[Therapeutic method derived from hiberno-therapy in excitation and agitation states].

J DELAY, P DENIKER, J M HARL.   

Abstract

Entities:  

Keywords:  HIBERNATION/artificial; MENTAL DISORDERS/therapy

Mesh:

Year:  1952        PMID: 13008201

Source DB:  PubMed          Journal:  Ann Med Psychol (Paris)        ISSN: 0003-4487            Impact factor:   0.380


× No keyword cloud information.
  31 in total

Review 1.  Clinical profile of clozapine: adverse reactions and agranulocytosis.

Authors:  J A Lieberman; A Z Safferman
Journal:  Psychiatr Q       Date:  1992

2.  Uses of chlorpromazine in mental hospital patients.

Authors:  J LOMAS
Journal:  Br Med J       Date:  1955-04-09

3.  [Effect of megaphen of the vaginal cycle in white rat].

Authors:  W KRAIS; H LEHR; W REISS
Journal:  Arch Gynakol       Date:  1954

4.  Uveal pigment and phenothiazine compounds.

Authors:  A M POTTS
Journal:  Trans Am Ophthalmol Soc       Date:  1962

5.  Tranquillizers and other psychotropic drugs in clinical practice.

Authors:  H E LEHMANN
Journal:  Can Med Assoc J       Date:  1958-11-01       Impact factor: 8.262

6.  Comparison of the effects of promazine and chlorpromazine in mental syndromes.

Authors:  H AZIMA; H DUROST
Journal:  Can Med Assoc J       Date:  1957-10-01       Impact factor: 8.262

7.  The clinical actions of major tranquillizers.

Authors:  M H Lader
Journal:  Proc R Soc Med       Date:  1977

Review 8.  The "delayed onset" of antipsychotic action--an idea whose time has come and gone.

Authors:  Ofer Agid; Phillip Seeman; Shitij Kapur
Journal:  J Psychiatry Neurosci       Date:  2006-03       Impact factor: 6.186

Review 9.  How antipsychotics work-from receptors to reality.

Authors:  Shitij Kapur; Ofer Agid; Romina Mizrahi; Ming Li
Journal:  NeuroRx       Date:  2006-01

Review 10.  Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Authors:  Richard B Mailman; Vishakantha Murthy
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.